v3.26.1
SCHEDULE OF OPTION ACTIVITY FOR NEURONOS (Details) - 2023 Neuro Nos Ltd Equity Incentive Plan [Member] - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Options, Outstanding at beginning of period 1,259,329  
Weighted Average Exercise Price - Options, Outstanding at beginning of period $ 0.24  
Weighted Average Remaining Contractual Life of Options, Outstanding 7 years 9 months 18 days 8 years 1 month 6 days
Aggregate Intrinsic Value, Outstanding at beginning of period $ 3,477  
Number of Options, Granted  
Weighted Average Exercise Price of Options, Granted  
Number of Options, Exercised  
Weighted Average Exercise Price of Options, Exercised  
Number of Options, Forfeited (478)  
Weighted average exercise price - options, forfeited $ 3.00  
Number of Options, Outstanding at ending of period 1,258,851 1,259,329
Weighted Average Exercise Price - Options, Outstanding at ending of period $ 0.24 $ 0.24
Aggregate Intrinsic Value, Outstanding at end of period $ 3,477 $ 3,477
Number of Options Outstanding, Exercisable 851,363  
Weighted Average Exercise Price - Options, Exercisable $ 0.18  
Weighted Average Remaining Contractual Life of Options, Exercisable 7 years 9 months 18 days  
Aggregate Intrinsic Value, Exercisable $ 2,404